258 related articles for article (PubMed ID: 34120306)
1. MicroRNA-17-5p Promotes Cardiac Hypertrophy by Targeting Mfn2 to Inhibit Autophagy.
Xu X; Su YL; Shi JY; Lu Q; Chen C
Cardiovasc Toxicol; 2021 Sep; 21(9):759-771. PubMed ID: 34120306
[TBL] [Abstract][Full Text] [Related]
2. miR-29a promotes pathological cardiac hypertrophy by targeting the PTEN/AKT/mTOR signalling pathway and suppressing autophagy.
Shi JY; Chen C; Xu X; Lu Q
Acta Physiol (Oxf); 2019 Oct; 227(2):e13323. PubMed ID: 31162869
[TBL] [Abstract][Full Text] [Related]
3. miR-106a promotes cardiac hypertrophy by targeting mitofusin 2.
Guan X; Wang L; Liu Z; Guo X; Jiang Y; Lu Y; Peng Y; Liu T; Yang B; Shan H; Zhang Y; Xu C
J Mol Cell Cardiol; 2016 Oct; 99():207-217. PubMed ID: 27565029
[TBL] [Abstract][Full Text] [Related]
4. MiR-100-5p regulates cardiac hypertrophy through activation of autophagy by targeting mTOR.
Zeng J; Wang L; Zhao J; Zheng Z; Peng J; Zhang W; Wen T; Nie J; Ding L; Yi D
Hum Cell; 2021 Sep; 34(5):1388-1397. PubMed ID: 34138410
[TBL] [Abstract][Full Text] [Related]
5. MiR-195-5p Promotes Cardiomyocyte Hypertrophy by Targeting MFN2 and FBXW7.
Wang L; Qin D; Shi H; Zhang Y; Li H; Han Q
Biomed Res Int; 2019; 2019():1580982. PubMed ID: 31341888
[TBL] [Abstract][Full Text] [Related]
6. Mitofusin 2 inhibits angiotensin II-induced myocardial hypertrophy.
Yu H; Guo Y; Mi L; Wang X; Li L; Gao W
J Cardiovasc Pharmacol Ther; 2011 Jun; 16(2):205-11. PubMed ID: 21106870
[TBL] [Abstract][Full Text] [Related]
7. Allicin attenuates pathological cardiac hypertrophy by inhibiting autophagy via activation of PI3K/Akt/mTOR and MAPK/ERK/mTOR signaling pathways.
Ba L; Gao J; Chen Y; Qi H; Dong C; Pan H; Zhang Q; Shi P; Song C; Guan X; Cao Y; Sun H
Phytomedicine; 2019 May; 58():152765. PubMed ID: 31005720
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-Dioxygenase 1 (IDO1) Promotes Cardiac Hypertrophy via a PI3K-AKT-mTOR-Dependent Mechanism.
Liu Y; Li S; Gao Z; Li S; Tan Q; Li Y; Wang D; Wang Q
Cardiovasc Toxicol; 2021 Aug; 21(8):655-668. PubMed ID: 34021461
[TBL] [Abstract][Full Text] [Related]
9. Expression Profile of microRNAs in Hypertrophic Cardiomyopathy and Effects of microRNA-20 in Inducing Cardiomyocyte Hypertrophy Through Regulating Gene
Sun D; Li C; Liu J; Wang Z; Liu Y; Luo C; Chen Y; Wen S
DNA Cell Biol; 2019 Aug; 38(8):796-807. PubMed ID: 31295012
[TBL] [Abstract][Full Text] [Related]
10. MiR-485-5p modulates mitochondrial fission through targeting mitochondrial anchored protein ligase in cardiac hypertrophy.
Zhao Y; Ponnusamy M; Liu C; Tian J; Dong Y; Gao J; Wang C; Zhang Y; Zhang L; Wang K; Li P
Biochim Biophys Acta Mol Basis Dis; 2017 Nov; 1863(11):2871-2881. PubMed ID: 28782654
[TBL] [Abstract][Full Text] [Related]
11. miR-337-5p promotes the development of cardiac hypertrophy by targeting Ubiquilin-1 (UBQLN1).
Ding Y; Wang J; Lu J
Bioengineered; 2021 Dec; 12(1):6771-6781. PubMed ID: 34515612
[TBL] [Abstract][Full Text] [Related]
12. Overexpression of microRNA-99a Attenuates Cardiac Hypertrophy.
Li Q; Xie J; Wang B; Li R; Bai J; Ding L; Gu R; Wang L; Xu B
PLoS One; 2016; 11(2):e0148480. PubMed ID: 26914935
[TBL] [Abstract][Full Text] [Related]
13. LncRNA RHPN1-AS1 inhibition induces autophagy and apoptosis in prostate cancer cells via the miR-7-5p/EGFR/PI3K/AKT/mTOR signaling pathway.
Ma X; Ren H; Zhang Y; Wang B; Ma H
Environ Toxicol; 2022 Dec; 37(12):3013-3027. PubMed ID: 36125241
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-223 protects neonatal rat cardiomyocytes and H9c2 cells from hypoxia-induced apoptosis and excessive autophagy via the Akt/mTOR pathway by targeting PARP-1.
Liu X; Deng Y; Xu Y; Jin W; Li H
J Mol Cell Cardiol; 2018 May; 118():133-146. PubMed ID: 29608885
[TBL] [Abstract][Full Text] [Related]
15. HTR2A promotes the development of cardiac hypertrophy by activating PI3K-PDK1-AKT-mTOR signaling.
Gao W; Guo N; Zhao S; Chen Z; Zhang W; Yan F; Liao H; Chi K
Cell Stress Chaperones; 2020 Nov; 25(6):899-908. PubMed ID: 32519137
[TBL] [Abstract][Full Text] [Related]
16. YQFM alleviated cardiac hypertrophy by apoptosis inhibition and autophagy regulation via PI
Wan M; Yin K; Yuan J; Ma S; Xu Q; Li D; Gao H; Gou X
J Ethnopharmacol; 2022 Mar; 285():114835. PubMed ID: 34798161
[TBL] [Abstract][Full Text] [Related]
17. Down-regulation of mitofusin-2 expression in cardiac hypertrophy in vitro and in vivo.
Fang L; Moore XL; Gao XM; Dart AM; Lim YL; Du XJ
Life Sci; 2007 May; 80(23):2154-2160. PubMed ID: 17499311
[TBL] [Abstract][Full Text] [Related]
18. Mitofusin2 Induces Cell Autophagy of Pancreatic Cancer through Inhibiting the PI3K/Akt/mTOR Signaling Pathway.
Xue R; Meng Q; Lu D; Liu X; Wang Y; Hao J
Oxid Med Cell Longev; 2018; 2018():2798070. PubMed ID: 30046371
[TBL] [Abstract][Full Text] [Related]
19. Attenuating PI3K/Akt- mTOR pathway reduces dihydrosphingosine 1 phosphate mediated collagen synthesis and hypertrophy in primary cardiac cells.
Magaye RR; Savira F; Hua Y; Xiong X; Huang L; Reid C; Flynn BL; Kaye D; Liew D; Wang BH
Int J Biochem Cell Biol; 2021 May; 134():105952. PubMed ID: 33609744
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of miR-146b-5p alleviates isoprenaline-induced cardiac hypertrophy via regulating DFCP1.
Liu S; Su L; Li J; Zhang Y; Hu X; Wang P; Liu P; Ye J
Mol Cell Endocrinol; 2024 Aug; 589():112252. PubMed ID: 38649132
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]